Pirbuterol acetate

醋酸吡布特罗

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePirbuterol acetate
Drug Alias NamePirbuterolum吡丁舒喘宁吡丁醇匹布特罗Maxair +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1986/12/30
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesBausch Health Companies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeR03AC08R03CC07